尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Parsons James T., 董事. Insider active across 2 companies, notably DiaMedica Therapeutics Inc.. Aggregated, 6 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 3 January 2022. The latest transaction was filed on 11 March 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Parsons James T. is a Director at DiaMedica Therapeutics Inc. and ONCOLYTICS BIOTECH INC. He has 6 filings in total, and across the 6 recent filings tracked here, purchases total 8871 EUR with no sales, over the period from 2022-01-03 to 2026-03-13. The most common transaction nature is Attribution.